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Nephrin and CD2AP Associate with Phosphoinositide 3-OH Kinase
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Mutations of NPHS1 or NPHS2, the genes encoding nephrin and podocin, as well as the targeted disruption
of CD2-associated protein (CD2AP), lead to heavy proteinuria, suggesting that all three proteins are essential
for the integrity of glomerular podocytes, the visceral glomerular epithelial cells of the kidney. It has been
speculated that these proteins participate in common signaling pathways; however, it has remained unclear
which signaling proteins are actually recruited by the slit diaphragm protein complex in vivo. We demonstrate
that both nephrin and CD2AP interact with the p85 regulatory subunit of phosphoinositide 3-OH kinase
(PI3K) in vivo, recruit PI3K to the plasma membrane, and, together with podocin, stimulate PI3K-dependent
AKT signaling in podocytes. Using two-dimensional gel analysis in combination with a phosphoserine-specific
antiserum, we demonstrate that the nephrin-induced AKT mediates phosphorylation of several target proteins
in podocytes. One such target is Bad; its phosphorylation and inactivation by 14-3-3 protects podocytes against
detachment-induced cell death, suggesting that the nephrin-CD2AP-mediated AKT activity can regulate com-
plex biological programs. Our findings reveal a novel role for the slit diaphragm proteins nephrin, CD2AP, and
podocin and demonstrate that these three proteins, in addition to their structural functions, initiate PI3K/
AKT-dependent signal transduction in glomerular podocytes.
The renal glomerulus is the site of a number of disorders
that lead to proteinuria and chronic renal failure (19, 25).
Recent studies of the hereditary nephrotic syndrome have em-
phasized the role of the glomerular podocytes in generating a
size-selective filtration barrier and have provided a new under-
standing of the mechanisms leading to proteinuria, in both
inherited and acquired diseases. The hereditary nephrotic syn-
drome is a heterogeneous disease characterized by heavy pro-
teinuria and renal failure. Mutations of NPHS1 (20) or NPHS2
(4, 13), the genes encoding the glomerular podocyte proteins
nephrin and podocin, as well as the targeted disruption of the
CD2-associated protein (CD2AP) in mice (43), lead to a se-
vere nephrotic syndrome, suggesting that these proteins are
indispensable for an intact glomerular filter. All three proteins
localize at opposing sites of the secondary foot processes
formed by podocytes, specialized epithelial cells that ensure
size- and charge-selective ultrafiltration (14, 15, 39, 41, 42).
This specialized cell-cell contact between opposing secondary
foot processes is called the slit diaphragm (38). Nephrin is a
member of the immunoglobulin superfamily and appears to
form a zipper-like filter structure within the 40-nm-wide slit
between two foot processes (reviewed in reference 48). It was
recently shown that nephrin is a signaling protein that interacts
with podocin, a podocyte protein of the stomatin family, facil-
itating nephrin signaling (18) and regulating its recruitment to
lipid raft microdomains (41, 45). CD2AP is an adaptor mole-
cule that was first identified as an SH3-containing protein that
binds to the cytoplasmic domain of CD2 (8). Mice lacking
CD2AP exhibit a nephrotic syndrome that resembles that
caused by NPHS1 mutations (43), suggesting that nephrin and
CD2AP participate in a common signaling pathway.
Phosphorylated lipids, such as PI(4,5)P2 and PI(3,4,5)P3, are
key mediators in diverse intracellular signaling pathways con-
trolling cell growth, cell migration, endocytosis, and cell sur-
vival (reviewed in reference 5). The conversion of PI(4,5)P2 to
PI(3,4,5)P3 at the inner leaflet of the plasma membrane is
catalyzed by phosphoinositide 3-OH kinases (PI3Ks). Class Ia
PI3Ks are heterodimers of regulatory and catalytic subunits.
The regulatory subunit p85 mediates the activation of the p110
catalytic counterpart by direct interaction with phosphoty-
rosine residues of activated transmembrane receptors or adap-
tor proteins. Signaling proteins with pleckstrin homology do-
mains then accumulate at sites of PI3K activation by directly
binding to newly generated PI(3,4,5)P3. A major downstream
mediator of PI3K activity is the serine-threonine kinase AKT.
Other PH domain-containing proteins that are activated by
PI(3,4,5)P3 include GDP-GTP exchange factors for Rac and
ARF6 and protein tyrosine kinases of the Bruton’s tyrosine
kinase (Btk) and Tec family. These proteins play a major role
in remodeling the actin cytoskeleton, the control of endocyto-
sis and protein trafficking, and cell survival (5). The binding of
PI3K-generated phospholipids to the PH domain of AKT leads
to the translocation of AKT to the inner surface of the plasma
membrane and induces conformational changes that are re-
quired for the proper phosphorylation and activation of AKT.
Relocalization of AKT to the plasma membrane allows the
close proximity of AKT to regulatory kinases that phosphory-
* Corresponding author. Mailing adress: Renal Division, University
Hospital Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany.
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FIG. 1. The carboxy-terminal cytoplasmic tail of nephrin interacts with p85. (A) C-terminally FLAG-tagged full-length nephrin (Nephrin.F)
was expressed in HEK 293T cells and immunoprecipitated with anti-FLAG antibody. Tyrosine phosphorylation was detected with the specific
antiphosphotyrosine antibody 4G10 (anti-PY; left). On the right is shown a reprobe with anti-FLAG antibody. (B) The cytoplasmic tail of nephrin
was fused to the CH2 and CH3 domains of human IgG1, followed by the transmembrane region of CD7 (sIg.7.nephrin1087-1241), and precipitated
with protein G-Sepharose beads. The CH2 and CH3 domains of human IgG1, followed by the transmembrane region of CD7 without a cytoplasmic
tail, served as the control (sIg.7). Tyrosine phosphorylation was detected with the antiphosphotyrosine-specific antibody 4G10 (anti-PY; left). On
the right are shown expression levels of the constructs (reprobe with anti-human IgG antibody). (C) C-terminally FLAG-tagged full-length nephrin
(Nephrin.F) was coexpressed with myc-tagged p85 or 14-3-3. After immunoprecipitation (IP) with the anti-myc antibody, the immobilized nephrin
was detected with the anti-FLAG antibody (top). The middle and lower blots show expression of the proteins in cell lysates. (D and E) myc.p85
was coexpressed with the constructs described for panel B. After precipitation with protein G, immobilized p85 was detected with a specific anti-p85
antibody. Prior to lysis and immunoprecipitation, cells were treated with solvent () or genistein (50 M; 30 min) () as indicated. (D) Top,
precipitates; bottom, lysates stained for p85. (E) Top, precipitates stained for p85; middle, lysates stained for p85; bottom, nephrin in precipitates
stained for phosphotyrosine. (F) myc.p85 was coexpressed with C-terminally FLAG-tagged full-length nephrin (Nephrin.F). After precipitation of
p85, nephrin was detected with anti-FLAG antibody and tyrosine phosphorylation of nephrin was detected with antiphosphotyrosine antibody.
Cells were treated with solvent or genistein (50 M, 30 min) prior to lysis and immunoprecipitation. Top, precipitates stained for nephrin; upper
middle, lysates stained for nephrin; lower middle, lysates stained for p85; bottom, nephrin in precipitates stained for phosphotyrosine. (G) To show
endogenous interaction, mouse kidneys were freshly isolated and perfused in situ with ice-cold phosphate-buffered saline and subjected to glass-
glass homogenization in a CHAPS lysis buffer. The precleared lysates were prepared by extensive centrifugation and preabsorption and
subsequently divided into two portions. One half was immunoprecipitated with a control antibody (Ab) (anti-HA antibody), and the other half was
precipitated with an anti-p85 antibody. Immobilized nephrin was detected with a nephrin-specific antiserum. (H) To confirm endogenous inter-
action, precleared lysates of mouse kidney were divided into two portions. One half was immunoprecipitated with a control antibody (anti-HA
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late AKT at two regulatory sites, threonine-308 and serine-473,
resulting in AKT activation (7). Among a wealth of effects,
AKT activity was found to be required for the growth factor-
dependent survival of a wide variety of cell types, ranging from
fibroblasts to neurons, and it blocks apoptosis induced by toxic
stimuli (reviewed in reference 6).
It has been speculated that nephrin, podocin, and CD2AP
participate in common signaling pathways; however, which sig-
naling proteins may interact at the cytosolic surface of the slit
diaphragm protein complex is still not clear. Here, we identify
p85, the regulatory subunit of PI3K, as the first signaling in-
termediate recruited by the slit diaphragm protein complex.
Using human embryonic kidney (HEK) 293T cells, a cell line
that lacks nephrin, podocin, and CD2AP, and cultured differ-
entiated mouse podocytes, we demonstrate that nephrin,
podocin, and CD2AP stimulate PI3K-dependent signaling
pathways. Our findings suggest that the activation of canonical
kinase cascades, such as PI3K/AKT signaling, represents an
essential component to maintain the functional integrity of
podocytes in vivo.
MATERIALS AND METHODS
Plasmids and antibodies. Nephrin, CD2AP, and podocin plasmids have been
described previously (18). Richard Mulligan (Harvard Medical School, Boston,
Mass.) and Dusty Miller (Fred Hutchinson Cancer Institute, Seattle, Wash.)
kindly provided the retroviral constructs pMD-G, pMD-gp, and pLXSN. To
generate retroviral gene transfer vectors, human nephrin and mouse CD2AP
were subcloned into pLXSN. The control vector was identical but did not contain
nephrin or CD2AP. All cloning steps were verified by automated sequencing.
FLAG-tagged regulator of G protein signaling 3 (RGS3) has been described (3).
HA.AKT wild type (pCMV-HA-AKT) and a dominant-negative mutant
(pCMV-HA-AKT K179 M) were kindly provided by Alex Toker (Boston, Mass.)
and Philip Tsichlis (Philadelphia, Pa.), pcDNA3-HA-AKT was a gift from Silvio
Gutkind (Bethesda, Md.), PI3K cDNA (pCMV6-p85-mycC) was kindly pro-
vided by Lewis Cantley and David Fruman (Boston, Mass.), pcDNA3-HA-
GSK-3 was provided by Jim Woodgett (Toronto, Canada), v-ras was provided
by Vikas Sukhatme (Boston, Mass.), and constitutively active AKT in pMX was
provided by Norihisa Masuyama (Tokyo, Japan). ntibodies were obtained from
Cell Signaling Technologies (anti-AKT, pSer473-AKT, GSK-3, pSer9-GSK-
3, 14-3-3 phospho-binding motif, pSer112-Bad, and pSer136-Bad), Sigma (anti-
actin and M2 anti-FLAG), Santa Cruz (anti-myc and antihemagglutinin [anti-
HA]), and Upstate Biotechnologies (anti-p85, anti-p110, and anti-PY 4G10).
Generation of an anti-CD2AP antiserum has been described (8). Immunopre-
cipitating nephrin antiserum was kindly provided by Lawrence B. Holzman (Ann
Arbor, Mich.).
Cell culture and retrovirus production. MDCK cells were grown in Dulbecco’s
modified Eagle medium–F-12 supplemented with 10% fetal calf serum. Condi-
tionally immortalized mouse podocytes were generated as described previously
(30, 36) and grown at permissive temperature in the presence of 10 U of gamma
interferon/ml. To induce differentiation, the cells were maintained on type I
collagen at 37°C without gamma interferon for at least 14 days. cd2ap/ podo-
cytes have been described previously (42). Conditionally immortalized cd2ap/
podocytes were derived from cd2ap/ mice crossed with a transgenic mouse
that expresses a temperature-sensitive form of simian virus 40 large T antigen
under the control of an interferon-inducible promoter. At the permissive tem-
perature, these cells grow continuously in culture. At the nonpermissive temper-
ature and after interferon removal, the cells stop growing, differentiate, and
acquire a podocyte-like morphology. Retrovirus for gene transfer was produced
by cotransfection of HEK 293T cells with 2.5 g of pMD-G, 7.5 g of pMD-gp,
and 10 g of the retroviral transfer vector. The supernatant was harvested,
centrifuged to remove cellular debris, and filtered. MDCK cells and mouse
podocytes were transduced three times and selected in G418 (200 g/ml) as
described previously (2).
Generation and purification of a nephrin-specific antiserum. A recombinant,
gel-purified nephrin fragment (amino acids 108to 1241)fused to the maltose-
binding protein (MBP) was used to immunize rabbits (Cocalico Biologicals,
Reamstown, Pa.), following a standard immunization protocol (2). Protein A
columns were used to affinity purify a nephrin-specific antiserum. Specificity was
verified by using bacterially expressed recombinant proteins, cell lysates from
transfected cells,and homogenized renal tissue.
Subcellular fractionation. HEK 293T cells were transiently transfected with
the appropriate constructs, serum starved overnight, and harvested and lysed at
4°C in a glass-glass homogenizer in 1 ml of homogenization buffer (250 mM
sucrose– 1 mM EDTA–20 mM Tris [pH 7.5]–44 g of phenylmethylsulfonyl
fluoride/ml–protease inhibitors). Nuclei were removed by centrifugation at 1,000
 g for 10 min at 4°C. The postnuclear supernatant was centrifuged at 100,000
 g for 30 min at 4°C. The supernatant (S100; soluble fraction) was collected,
and the pellet (P100; membrane fraction) was washed once in homogenization
buffer and then resuspended in lysis buffer containing 1% Triton X-100 and 0.2%
sodium dodecyl sulfate (SDS). The protein concentration was determined, and
equal amounts of protein were separated by SDS–10% polyacrylamide gel elec-
trophoresis.
Coimmunoprecipitation. Coimmunoprecipitations were performed as de-
scribed previously (3). Briefly, HEK 293T cells were transiently transfected using
the calcium phosphate method. After incubation for 24 h, the cells were washed
twice and lysed in 1% Triton X-100 lysis buffer. After centrifugation at 15,000 
g (15 min; 4°C) and ultracentrifugation at 100,000  g (30 min; 4°C), cell lysates
containing equal amounts of total protein were precleared with protein G-
Sepharose and then incubated for 1 h at 4°C with the appropriate antibody,
followed by incubation with 40 l of protein G-Sepharose beads for 3 h. The
beads were washed extensively with lysis buffer, and bound proteins were re-
solved by SDS–10% polyacrylamide gel electrophoresis. In kidney cortex and
cultured podocytes, nephrin, podocin, and CD2AP are contained within lipid raft
microdomains and are therefore insoluble in nonionic detergents, such as Triton
X-100. Therefore, the lysis buffer was supplemented with 20 mM CHAPS
{3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate}. Sufficient sol-
ubilization was monitored by Western blotting of different fractions during the
preparation. Before immunoprecipitation, cellular lysates were extensively pre-
cleared by ultracentrifugation and adsorption to protein G beads. All kidneys
were freshly prepared and perfused in situ with ice-cold phosphate-buffered
saline before lysis.
2-D gel analysis. Equal amounts of protein from cells transfected with nephrin,
CD2AP, podocin, or control plasmid in combination with wild-type AKT or a
dominant-negative mutant were separated on a two-dimensional (2-D) gel. In
the first dimension, proteins were separated by isoelectric focusing (Bio-Rad,
Munich, Germany). The second dimension separated the proteins according to
their molecular weights. After 2-D electrophoresis, proteins were blotted onto
polyvinylidene difluoride (PVDF) membranes, blocked with 5% bovine serum
albumin, and stained with antibodies as appropriate.
Protein phosphorylation. To determine the phosphorylation status of AKT,
GSK-3, and Bad, specifically phosphorylated residues were visualized by West-
ern blot analysis, using phosphospecific antisera (Cell Signaling Technologies).
Equal loading was confirmed by reprobing the membrane with the non-phospho-
specific antibodies and by amido black staining. The degrees of phosphorylation
of AKT, GSK-3, and Bad were quantified by densitometry of nonsaturated
radiographs with NIH Image software.
Anoikis assays, DNA laddering, caspase 3 activity assays, and annexin V
binding. Anoikis assays, as well as DNA laddering, were performed essentially as
described previously (21). Caspase 3 activity was monitored in a quantitative
fluorescence assay using a commercially available caspase 3 substrate. Briefly,3
 106 cells, retrovirally transduced to stably express the appropriate transgenes,
were detached from cell culture dishes, and equal numbers of cells were main-
tained in suspension for 2 to 12 h. Thereafter, cells were harvested and lysed in
antibody), and the other half was precipitated with an antinephrin antibody. Immobilized p85 was detected with a p85-specific antiserum (bottom).
On top is shown the coprecipitating enzymatically active p110 subunit of PI3 kinase, indicating that nephrin interacts with the active heterodimer
of PI3K. (I) myc.p85-expressing HEK 293T cells were transfected with FLAG-tagged nephrin or with FLAG-tagged RGS3 (F.RGS3) as a control
protein. Recruitment of myc.p85 to the membrane compartment was monitored by preparing a 100,000  g pellet (P100 [Membrane]) and a
100,000  g supernatant fraction (S100 [Cytosol]).
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a glass-glass homogenizer at 4°C in 200 l of 30 mM NaCl–50 mM NaF–25 mM
Na4P2O7–0.1 mM EDTA–20 mM Tris [pH 7.5]–44 g of phenylmethylsulfonyl
fluoride/ml–protease inhibitors. The lysate was centrifuged at 100,000  g for 30
min at 4°C, and the supernatant (cytosolic fraction) was collected. Caspase 3
activity was determined as described previously (32). Briefly, 6 ng of fluorogenic
caspase 3 substrate, Ac-DEVD-AMC (Alexis Biochemicals, San Diego, Calif.),
was added to 100 l of the cytosolic extract in a 96-well plate. Fluorescence was
determined (excitation at 380 nm and emission at 420 to 460 nm) at 30°C for 30
min. The slope of the linear curve obtained over 30 min of registration was used
as a measure for enzyme activity. Quantitation of apoptosis by annexin V binding
was performed as described elsewhere (10a). Briefly, differentiated podocytes
were detached and kept in suspension culture for various times, washed once in
phosphate-buffered saline, and resuspended in annexin V binding buffer (R&D
Systems). Fluorescein isothiocyanate-conjugated annexin V was added, and the
samples were analyzed by flow cytometry with a FACScan (Becton Dickinson).
Cells were plated at identical initial densities, and quantitation was done with
Cell Quest software. All experiments were done in triplicate. Statistical analysis
was performed using the statistical software Instat2 (GraphPad) and SigmaPlot
(Jandel Scientific).
Statistical analysis. Data are expressed as means 	 standard errors of the
mean (SEM) of n experiments. Statistical evaluation was performed using Stu-
dent’s t test or analysis of variance for repeated measures, followed by a Bon-
ferroni test (SigmaPlot and Instat2). P values of 
0.05 were considered to be
statistically significant.
RESULTS
Nephrin and CD2AP associate with the p85 regulatory sub-
unit of PI3K. The immunoglobulin family member nephrin is
a critical structural component of the podocyte slit diaphragm.
Based on the structure of the glomerular slit diaphragm (38)
and the electron microscopic localization of nephrin (39), it
has been suggested that the N-terminal six immunoglobulin
repeats of nephrin form interdigitating zipper-like homo- and
heterophilic interactions (39, 47). Using HEK 293T cells as a
model system, it was recently demonstrated that nephrin stim-
ulates cellular signaling that is augmented by podocin (18). It
has been speculated that nephrin, podocin, and CD2AP par-
ticipate in common signaling pathways; however, it is still not
clear which signaling proteins may be recruited by the slit
diaphragm protein complex. We therefore started to search for
nephrin-interacting cytosolic proteins. The carboxy-terminal
domain of nephrin is relatively short but contains several po-
tential tyrosine phosphorylation sites. In particular, Y1176,
Y1193, and Y1210 are predicted to serve as potential docking
sites for SH2 domain-containing adaptor and signaling mole-
cules (53; http://scansite.mit.edu/). As demonstrated in Fig.
1A, nephrin was heavily tyrosine phosphorylated in transiently
transfected HEK 293T cells. Identical results were obtained
when the cytoplasmic tail of nephrin was fused to the CH2 and
CH3 domain of human immunoglobulin G1 (IgG1), followed
by the transmembrane region of CD7 (Fig. 1B). Interestingly,
the tyrosine-phosphorylated carboxy-terminal domain of neph-
rin associated with p85 (Fig. 1C and D), the regulatory subunit
of PI3K, whereas no binding of other SH2 domain-containing
proteins, including Grb2, Shc, and CrkII, was observed (data
not shown). This interaction could also be demonstrated for
endogenous proteins precipitated from mouse kidney lysates
(Fig. 1G and H), confirming that the interaction occurs in vivo.
Pretreatment of HEK 293T cells with genistein, a tyrosine
kinase inhibitor with some preference for the src family of non-
receptor protein tyrosine kinases, inhibited tyrosine phosphor-
ylation of the cytoplasmic tail of nephrin and the interaction
with p85 (Fig. 1E and F), suggesting that the binding of p85
requires nephrin tyrosine phosphorylation. Finally, expression
of nephrin in serum-starved HEK 293T cells resulted in the
association of p85 with the plasma membrane, demonstrating
that nephrin recruits PI3K to the plasma membrane (Fig. 1I).
CD2AP was originally cloned as a CD2-interacting protein
(8). Targeted disruption of the cd2ap gene in mice causes a
severe nephrotic syndrome 3 to 4 weeks after birth (43).
CD2AP contains three consecutive SH3 domains at the amino
terminus, followed by a proline-rich domain, a coiled-coiled
domain, and a potential monomeric actin binding domain.
CD2AP has been shown to bind to the cytoplasmic tail of
nephrin via a novel carboxy-terminal domain (27, 42). Inter-
estingly, CD2AP also interacted with p85 (Fig. 2A). This in-
teraction was mediated by the N-terminal portion (amino acids
1 to 334) of CD2AP, containing the three SH3 domains (Fig.
2B and C), and was detectable in vivo between endogenous
proteins (Fig. 2D and E). As described previously, CD2AP not
only interacted with p85 but also coprecipitated nephrin in vivo
(Fig. 2F). These data suggested that nephrin and CD2AP may
indeed participate in a common signaling pathway.
Nephrin and CD2AP induce phosphorylation and activation
of the PI3K target protein kinase, AKT. PI3K can initiate
cellular signaling through activation of a number of cellular
intermediates, including tyrosine kinases, GTPase activating
proteins for small G proteins, and a variety of serine-threonine
kinases, such as the atypical PKC isoforms, pp70 S6 kinase, and
c-AKT. Recent findings have revealed a critical role for AKT
as a mediator of PI3K-dependent cellular events (6, 7). Since
overexpression of cell surface receptors (51, 58) and adaptor
proteins (16, 17, 33) can initiate signaling in a ligand-indepen-
dent fashion, we determined whether expression of nephrin,
CD2AP, and/or podocin triggers PI3K-dependent signaling in
HEK 293T cells. Figure 3A demonstrates that nephrin triggers
phosphorylation of AKT on serine 473. CD2AP stimulated
AKT with similar potency (Fig. 3A). In contrast, little if any
activation was detectable in HEK 293T cells expressing podo-
cin (Fig. 3B and C). However, both podocin and CD2AP
strongly augmented the nephrin-induced AKT activation (Fig.
3C) without affecting the expression levels of nephrin (data not
shown). The nephrin- and CD2AP-induced AKT phosphory-
lation was completely inhibited by the PI3K inhibitor wortman-
nin, demonstrating that the phosphorylation and activation of
AKT is PI3K dependent (data not shown).
To demonstrate that nephrin triggers AKT activation in
podocytes, we generated pools of conditionally immortalized
mouse podocytes stably expressing nephrin. These podocytes
were generated as previously described (30, 36) and have been
extensively characterized (H. Pavensta¨dt, unpublished data).
Mouse podocytes were transduced repeatedly at the permissive
temperature of 33°C with an ecotropic retrovirus containing
the nephrin cDNA (nephrin) or the control vector (2). After
selection in neomycin, the podocytes were incubated at 37°C in
the absence of gamma interferon to induce differentiation.
While conditionally immortalized differentiated podocytes
contain only low levels of nephrin protein (42, 55), the retro-
virus-mediated nephrin expression resulted in activation of
AKT, monitored with the phosphoserine-473-specific AKT an-
tiserum (Fig. 3E). Equal loading was confirmed by reprobing
the membrane with anti--tubulin and with anti-AKT antibod-
ies. Nephrin expression was monitored with an affinity-purified
antiserum that specifically recognized nephrin, as shown in Fig.
4920 HUBER ET AL. MOL. CELL. BIOL.
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3D. The nephrin-induced AKT activation was confirmed in five
independent experiments (Fig. 3F), confirming the results ob-
tained in transiently transfected HEK 293T cells. To further
substantiate the role of CD2AP in AKT activation in podo-
cytes, we examined AKT phosphorylation in podocytes derived
from cd2ap knockout mice. As demonstrated in Fig. 3G, the
loss of CD2AP strongly inhibited AKT activation induced by
epidermal growth factor (EGF), while EGF-induced ERK1/2
activation was not reduced (data not shown). These findings
suggest that both nephrin and CD2AP are involved in PI3K
and AKT activation.
To confirm the nephrin-mediated AKT activation, we mon-
itored the phosphorylation of glycogen synthase kinase 3
(GSK-3) in HEK 293T cells expressing nephrin. GSK-3 is a
ubiquitously expressed serine-threonine protein kinase that
phosphorylates and inactivates glycogen synthase, a critical
downstream element of the PI3K/AKT pathway. Its activity
can be inhibited by AKT-mediated phosphorylation at serine-
9. Both nephrin and CD2AP strongly increased phosphoryla-
tion of GSK-3 (Fig. 4A to C). Statistical analysis revealed that
the nephrin-mediated effect was strongly augmented by podo-
cin and by CD2AP (Fig. 4D). Both AKT phosphorylation and
activation could be completely blocked by the highly selective
PI3K inhibitor LY 294002 (Fig. 4E and F), confirming that the
nephrin- and CD2AP-mediated stimulation of AKT requires
activation of PI3K. In summary, these data demonstrate that
both nephrin and CD2AP stimulate PI3K-dependent signaling
in HEK 293T cells, as well as in podocytes.
FIG. 2. CD2AP interacts with p85. (A) myc.p85 was coexpressed with FLAG-tagged CD2AP (F.CD2AP) or the control protein GFP. After
immunoprecipitation (IP) with anti-FLAG antibody, coprecipitating myc.p85 was detected with a p85-specific antibody (top). The middle and
lower gels show protein expression in the lysates. (B and C) The interaction of p85 occurs with the amino-terminal portion of CD2AP, a region
containing all three SH3 domains and a highly tyrosine-phosphorylated segment (top). The middle and lower gels show protein expression in the
lysates. (D and E) To demonstrate endogenous interaction, freshly isolated kidneys were lysed in CHAPS lysis buffer and subjected to immuno-
precipitation with control antibody (Ab) (anti-HA antibody) and anti-85 polyclonal antibody or anti-CD2AP polyclonal antibody. Prior to
immunoprecipitation, the lysates were precleared extensively to ensure specific coprecipitation. Coprecipitating CD2AP (D) or p85 (E) protein was
detected with a specific antiserum. (F) As previously shown, endogenous nephrin coprecipitated with CD2AP.
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Identification of downstream target proteins of nephrin-
induced PI3K/AKT signaling. To further substantiate the rel-
evance of our finding that nephrin and CD2AP interact with
PI3K and stimulate PI3K-dependent signaling, we started to
search for downstream target proteins of the nephrin-CD2AP-
mediated PI3K/AKT activity. The search for substrates of
AKT has been facilitated by the definition of a consensus
sequence of the preferred AKT in vitro phosphorylation site,
FIG. 3. Nephrin and CD2AP stimulate phosphorylation of AKT at serine-473. (A and B) HEK 293T cells were transfected with HA.AKT (5 g)
together with vector (10 g; left lane), nephrin (5 g plus 5 g of vector; second lane from left), CD2AP (5 g plus 5 g of vector; third lane from
left), nephrin and CD2AP (5 plus 5 g; fourth lane from left), or v-ras (5 g plus 5 g of vector; fifth lane from left) as indicated (A) or together
with vector (10 g; left lane), nephrin (5 g plus 5 g of vector, second lane from left), nephrin and podocin (5 plus 5 g; third lane from left),
or podocin (5 g plus 5 g of vector; fourth lane from left) as indicated (B). Phosphorylation of AKT was monitored with a specific anti-phospho-
serine-473 antibody (top and middle). Equal loading and comparable expression of AKT was confirmed by reprobing the blots with a non-phos-
phospecific anti-AKT antiserum (middle). Equal expression levels of nephrin, CD2AP, and podocin were demonstrated by using the respective
antibodies (bottom). F, FLAG. (C) The degree of phosphorylation of AKT was quantified by densitometry of nonsaturated radiographs with NIH
Image software. Depicted is the statistical analysis of 10 independent experiments (*, P
 0.05; **, P
 0.01; n 10). The error bars indicate SEM.
(D) To generate a nephrin-specific antiserum, recombinant MBP-tagged nephrin (amino acids 1087 to 1241) was bacterially expressed, affinity
purified by fast protein liquid chromatography, and used for the immunization of rabbits. The purified antiserum specifically recognizes nephrin
but does not cross-react with other proteins. (E) To test whether nephrin induces AKT activation in podocytes, conditionally immortalized mouse
podocytes were retrovirally transduced with nonexpressing retrovirus (Control) or to stably express nephrin (Nephrin), differentiated at 37°C, and
assayed for AKT phosphorylation (phospho-serine-473 [pSer473] antibody; top), expression of endogenous AKT (upper middle), and nephrin
expression (lower middle). Equal loading was confirmed by reprobing the membrane with anti--tubulin antibody (bottom). (F) Densitometric analysis
of five independent experiments in podocytes. The degree of phosphorylation of AKT was quantified by densitometry of nonsaturated radiographs
with NIH Image software (*, P 
 0.05; n  5). (G) To further substantiate the role of CD2AP in AKT activation in podocytes, we examined AKT
phosphorylation in podocytes derived from cd2ap knockout mice. The loss of CD2AP strongly inhibited AKT activation induced by EGF, whereas
EGF-induced ERK1/2 activation was not reduced (not shown). These findings further substantiate the role of CD2AP in PI3K/AKT activation.
Top, AKT phosphorylation of wild type (wt) and CD2AP knockout (CD2AP/) podocytes. Bottom, actin level as a loading control.
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RXRXXS/T (1, 34). After phosphorylation, several AKT tar-
gets bind to the 14-3-3 family of adaptor proteins, resulting in
their cellular redistribution and/or inactivation (49). The 14-
3-3 proteins are a highly conserved family of proteins involved
in the regulation of cell survival, apoptosis, proliferation, and
cell cycle control. Regulation by 14-3-3 is mediated through
phosphorylation-dependent protein-protein interactions (37,
52, 54). Thus, phosphorylation-dependent binding of 14-3-3 to
target proteins is a critical event in AKT-mediated cellular
programs (7). To analyze the set of target proteins phosphor-
ylated in nephrin-induced AKT activation, we therefore used a
phosphospecific antiserum raised against the 14-3-3 mode 1
binding motif (31, 54) in combination with 1- and 2-D gel
analysis. Equal amounts of protein from cells expressing or
FIG. 4. Nephrin, CD2AP, and podocin cooperatively activate the PI3K/AKT pathway. To monitor AKT activity, phosphorylation of GSK-3
at serine-9 was measured in HEK 293T cells transfected with identical amounts of plasmid DNA, as indicated (A, B, C, E, and, F, top). The cells
were cotransfected with 4 g of myc.AKT and 4 g of GSK-3; with 8 g of vector for vector alone and 4 g of expression plasmid plus 4 g of
vector for nephrin, podocin, CD2AP, or v-Ras alone; and with 4 plus 4 g of plasmid DNA for nephrin plus CD2AP or nephrin plus podocin. This
approach ensured equal expression levels of the relevant cDNAs and allowed statistical analysis of several independent experiments. Equal loading
and comparable expression of AKT and GSK-3 were confirmed by reprobing the blots with nonphosphospecific anti-AKT and anti-GSK-3
antisera (middle and bottom) and with the relevant antisera against podocin, nephrin, and CD2AP (not shown). (D) The degree of phosphorylation
was quantified by densitometry of nonsaturated radiographs with NIH Image software. Depicted is the statistical analysis of 10 independent
experiments (*, P 
 0.05; **, P 
 0.01; n  10). The error bars indicate SEM. (E and F) Incubation of cells with () the specific PI3K inhibitor
LY 294002 (25 M; 30 min) abrogated nephrin-CD2AP-stimulated AKT activation and AKT-mediated GSK-3 phosphorylation.
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lacking nephrin, CD2AP, and podocin in combination with
wild-type AKT or a dominant-negative AKT mutant were sep-
arated on 1- or 2-D gels. 1-D gel electrophoresis showed a
large number of proteins being phosphorylated at putative
14-3-3 binding sites (data not shown). Since the resolution was
insufficient, 2-D gel electrophoresis was utilized for further
analysis. As depicted in Fig. 5A, the three podocyte proteins
stimulated the phosphorylation of several target proteins,
thereby creating a putative 14-3-3 binding site. Depicted in Fig.
5A are the most prominent spots. This phosphorylation was
strictly dependent on AKT activity and was abolished by the
coexpression of the dominant-negative AKT mutant. Interest-
FIG. 5. Identification of downstream target proteins of nephrin-CD2AP-podocin-stimulated AKT activity. (A) Equal amounts of protein from
HEK 293T cells transfected with either a vector control (9 g of plasmid) or nephrin (3 g), CD2AP (3 g), and podocin (3 g) in combination
with either wild-type (WT) AKT or a dominant-negative mutant (DNM) were separated on a 2-D gel. To analyze the formation of active 14-3-3
binding sites associated with the nephrin-CD2AP-podocin-stimulated AKT activity, cell lysates were transferred onto PVDF membranes and
immunoblotted with a phosphospecific antiserum raised against the 14-3-3 mode 1 binding motif (left). Lysates from these cells showed comparable
AKT expressions (right). F, FLAG; IEF, isoelectric focusing. (B and C) The proapoptotic Bcl2 family member Bad is regulated by AKT-dependent
phosphorylation on serine-112 (pSer112) and serine-136. Equal amounts of protein from HEK 293T cells expressing either a vector control (9 g
of plasmid) or nephrin (3 g), CD2AP (3 g), and podocin (3 g) in combination with wild-type AKT were separated on a 2-D gel. Nephrin,
podocin, and CD2AP induced the phosphorylation of endogenous Bad on both regulatory sites, serine-112 and serine-136, as demonstrated by the
phosphospecific antiserum (B), whereas AKT expression was not influenced (not shown). The same result, although with a weaker effect, could
be demonstrated with nephrin alone (C). Circles indicate spots identified with phosphospecific antiserum against 14-3-3 mode 1 binding motif (A)
or with phosphospecific antisera against Bad (B and C).
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ingly, a prominent protein detected by the phosphospecific
antiserum had a molecular mass of 23 kDa and a pI of 6.
Additional experiments identified this protein as Bad (Fig. 5B
and C). Bad is a proapoptotic Bcl-2 family member that inter-
acts via its BH3 domain with prosurvival Bcl-2 family members,
such as Bcl-XL, to inhibit their prosurvival activity and pro-
mote apoptosis (56). Bad is regulated by AKT-dependent
phosphorylation on serine-112 and serine-136 (6). Phosphory-
lation of either of these sites causes Bad to dissociate from
Bcl-XL and to associate with 14-3-3, thereby promoting cell
survival at a postmitochondrial level (59). Nephrin, podocin,
and CD2AP induced the phosphorylation of Bad on both reg-
ulatory sites (Fig. 5B and C). These data suggested that the
nephrin-induced PI3K/AKT activation may trigger antiapopto-
tic signaling and confirmed that Bad is a major substrate for
AKT-dependent 14-3-3 binding in HEK 293T cells. Identical re-
sults were obtained in differentiated podocytes (Fig. 6). Neph-
rin expression was associated with the phosphorylation of sev-
eral target proteins with molecular masses of 70, 65, 30, and
23 kDa; the last spot was confirmed as phospho-Bad (not shown).
Nephrin-mediated activation of the PI3K/AKT pathway reg-
ulates complex biological programs. Among a wealth of effects
of PI3K/AKT activity, the PI3K-induced AKT signaling path-
way is one of the main antiapoptotic cell survival pathways
known. AKT-mediated phosphorylation of Bad has been shown
to prevent different modes of apoptosis. To demonstrate that
nephrin-mediated PI3K activation can regulate complex cellu-
lar programs, we investigated whether nephrin protects cells
against apoptosis. Detachment of epithelial cells, such as
MDCK cells, from the extracellular matrix triggers pro-
grammed cell death, a phenomenon known as anoikis (12),
while integrin-mediated binding of MDCK cells to the matrix
leads to rapid stimulation of the PI3K/AKT signaling pathway
that prevents apoptosis (21). Thus, the loss of PI3K/AKT ac-
tivity after detachment appears to induce cell death. We tested
whether expression of nephrin in this well-defined model of
anoikis compensates for the loss of integrin-mediated AKT
activation. MDCK cells were transduced to express nephrin
(Fig. 7B). Apoptosis rates were monitored by DNA laddering,
as well as by caspase 3 activation. Detachment of MDCK cells
from the matrix induced a time-dependent dramatic increase
in apoptosis, as demonstrated by DNA laddering (Fig. 7A) and
caspase 3 activity (Fig. 7B). Expression of nephrin significantly
inhibited apoptosis compared to that in control cells (Fig. 7A
to C). The survival benefit of nephrin-expressing cells was
completely reversed by wortmannin, indicating that nephrin
exerts its survival effect via the PI3K/AKT pathway (Fig. 7D).
To show that regulation of cell viability may be an important
aspect of PI3K signaling in podocytes, we subjected control
and nephrin-expressing podocytes to anoikis. Interestingly, cul-
tured differentiated podocytes are surprisingly resistant to a
variety of apoptotic stimuli (T. B. Huber, B. Hartleben, M.
Schmidts, G. Walz, and T. Benzing, unpublished data), but are
exquisitely sensitive to detachment. In perfect agreement with
the MDCK model of anoikis, the expression of nephrin in
differentiated mouse podocytes strongly inhibited detachment-
induced apoptosis in podocytes (Fig. 7E). Interestingly, the
nephrin-mediated survival benefit was comparable to the ex-
pression of a constitutively active mutant of AKT (Fig. 7E),
and nephrin expression facilitated the maintenance of AKT
and BAD phosphorylation after the induction of apoptosis
(Fig. 7F), further supporting the concept that nephrin-me-
diated AKT activation can protect podocytes from under-
going apoptosis. Conditionally immortalized differentiated
podocytes contain only low levels of nephrin protein but
relatively large amounts of CD2AP. To demonstrate that
CD2AP-mediated AKT activation also participates in a
pathway that safeguards podocytes against apoptotic signals,
we examined detachment-induced apoptosis in podocytes
derived from cd2ap knockout mice. As shown in Fig. 7G,
the loss of CD2AP dramatically increased susceptibility to
detachment-induced apoptosis compared to wild-type podo-
cytes. However, there was no difference between the spon-
taneous apoptosis rates of cd2ap/ and wild-type podo-
cytes. These findings suggest that both nephrin and CD2AP
participate in PI3K/AKT signaling that safeguards podocyte
viability and provide proof that nephrin-CD2AP-mediated
PI3K activation can regulate complex biological programs.
DISCUSSION
Recent studies have emphasized the role of the podocyte slit
diaphragm as a crucial size-selective filtration barrier in the
kidney and have revealed novel aspects of the mechanisms
leading to proteinuria in both inherited and acquired diseases
(19, 46). However, it is unclear how the loss of either nephrin,
podocin, or CD2AP causes the functional changes that abolish
FIG. 6. Nephrin expression induces phosphorylation of several tar-
get proteins at putative 14-3-3 binding sites in differentiated mouse
podocytes. Equal amounts of protein from differentiated mouse podo-
cytes transduced with empty retroviral vector (Control) or to stably
express nephrin (Nephrin) were separated on a 2-D gel. To analyze the
phosphorylation of target proteins associated with the nephrin-stimu-
lated AKT activation, cell lysates were transferred onto PVDF mem-
branes and immunoblotted with a phosphospecific antiserum raised
against the 14-3-3 mode 1 binding motif (circles indicate spots identi-
fied with that antiserum). IEF, isoelectric focusing.
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FIG. 7. Nephrin-mediated PI3K/AKT activation is associated with inhibition of apoptotic cell death. (A to D) The MDCK cell model of anoikis
was used to test whether nephrin-stimulated AKT activity was associated with an inhibition of apoptosis. MDCK cells were retrovirally transduced
to express nephrin and subjected to apoptosis assays (DNA laddering [A] and quantitative caspase 3 activity [B to D]) as described in Materials and
Methods. (A) DNA-laddering assay. Lane 1, DNA marker; lane 2, control cells without detachment; lane 3, anoikis in cells transduced with control virus;
lane 4, anoikis in cells transduced with nephrin retrovirus. (B) Time course of quantitative caspase 3 activity in cells transduced with control virus (n 
3; shaded circles) and nephrin-transduced cells (n  3; solid circles). The inset shows that these cells express nephrin. FLAG-tagged full-length
nephrin (Nephrin.F), expressed in 293T cells, served as a positive control for the blot. The error bars indicate SEM. (C) Statistical analysis of the
nephrin effect on quantitative caspase 3 activity after induction of anoikis (n  6; **, P 
 0.01). (D) Effect of wortmannin treatment (100 nM; 120 min)
() on quantitative caspase 3 activity in control and nephrin-expressing cells (n 4; *, P
 0.05). (E) Nephrin expression and constitutively active AKT
inhibit detachment-induced apoptosis in differentiated mouse podocytes. Mouse podocytes were retrovirally transduced to stably express nephrin or a
constitutively active mutant of AKT. The differentiated mouse podocytes were detached and kept in suspension culture for 4 h. Equal amounts of protein
from cell lysates were subjected to caspase 3 activity assays as described in Materials and Methods. Depicted is a statistical analysis of six (control [open
column] versus nephrin [solid column]) and four (control [open column] versus constitutively active AKT [shaded column]) independent experiments (**,
P 
 0.01). (F) Nephrin expression maintains AKT and Bad phosphorylation after induction of anoikis. Differentiated control or nephrin-expressing
podocytes were detached and kept in suspension culture for 4 h. Phosphorylation of AKT at serine-473 (pSer473; top) and Bad at serine-112
(middle) were monitored with phosphospecific antibodies; equal loading of proteins was confirmed by reprobing the membrane with an antitubulin
antibody (bottom). (G) Increased susceptibility of cd2ap/ podocytes to detachment-induced apoptosis. cd2ap/ and cd2ap/ podocytes were
differentiated, detached from the cell culture dish, and kept in suspension culture (2 h [left]; 4 h [right]). Programmed cell death was evaluated by annexin
V binding as described in Materials and Methods (**, P 
 0.01, and ***, P 
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the formation of slit diaphragms, alter the morphology of podo-
cytes, and eventually result in podocyte depletion. It has been
speculated that these proteins participate in common signaling
pathways; however, it has remained unclear which signaling
proteins are recruited by the slit diaphragm protein complex
in vivo.
We found that the carboxy-terminal cytoplasmic tail of
nephrin and CD2AP interact with the p85 regulatory subunit
of PI3K. This could be shown with endogenous proteins from
mouse kidney cortex. Thus, PI3K is the first protein demon-
strated to interact with the cytoplasmic surface of the slit dia-
phragm protein complex in vivo. The interaction of nephrin
with PI3K was phosphotyrosine dependent and susceptible to
genistein, a broad-spectrum tyrosine kinase inhibitor with pref-
erence for protein tyrosine kinases of the src family. Two other
observations suggest that src family members mediate the
downstream signaling of nephrin: first, the carboxy-terminal
cytoplasmic tail of nephrin is phosphorylated by src kinases in
vivo (50), and second, targeted disruption of the src family
member fyn in mice results in massive proteinuria (57). The
renal phenotype is preserved in fyn/ rag1/ double-mutant
mice, which lack functional B or T lymphocytes, suggesting
that the kidney manifestations of fyn/ mice are due to an
intrinsic glomerular defect. Fyn deficiency results in podocyte
foot process fusion and eventually podocyte loss, a result al-
most identical to that of nephrin deficiency in both mice (35)
and humans (20). These observations suggest that regulated
tyrosine phosphorylation of the cytoplasmic tail of nephrin by
src family members, and the phosphorylation-dependent inter-
action with SH2 domain-containing signaling molecules, such
as p85, are critical for the integrity of the glomerular filter.
Interaction of p85 with nephrin and CD2AP was associated
with a strong activation of AKT. It has been shown that neph-
rin interacts with podocin and that this interaction facilitates
nephrin signaling (18). Data from several laboratories suggest
that podocin functions to recruit nephrin and CD2AP to lipid
rafts localized at the slit diaphragm (18, 41, 42, 45). Our results
demonstrate that both nephrin and CD2AP induce PI3K-de-
pendent signaling. Hence, the slit diaphragm proteins nephrin,
CD2AP, and podocin appear to serve at least two functions.
First, these proteins are indispensable for the structural orga-
nization of the slit diaphragm. Second, nephrin interacts with
podocin, CD2AP, and cytoplasmic adaptor proteins, such as
the p85 subunit of PI3K, to initiate signaling from the slit
diaphragm. This nephrin-induced signaling cascade was estab-
lished in three independent models, HEK 293T cells, MDCK
cells, and in vitro-differentiated podocytes. In addition, the
functional consequences of the loss of CD2AP for AKT acti-
vation were validated in podocytes derived from CD2AP-de-
ficient mice. Hence, both tyrosine phosphorylation of nephrin
and the stimulation of PI3K appear to represent important
aspects of the signaling events that originate at the slit dia-
phragm of glomerular podocytes. PI3K and AKT control
complex cellular programs, including regulation of gene ex-
pression, migration, remodeling of the actin cytoskeleton, en-
docytosis, and the control of cell viability and growth (5).
Interestingly, AKT is also required to repress collagenase ex-
pression and to induce the synthesis of laminin and type IV
collagen chains (28, 29); both are key components of the glo-
merular basement membrane. Since basement membrane ab-
normalities are involved in the development of several forms of
proteinuria, AKT activation may contribute to the synthesis
and/or maintenance of an intact glomerular basement mem-
brane. In addition, AKT signaling transactivates cell surface
receptors (26) and modifies cellular metabolism (5, 9, 23, 44).
Moreover, it has been shown that AKT provides a strong
survival signal that protects cells from death induced by various
stresses (7). Podocyte death and podocyte depletion have been
proposed as hallmarks of both primary and secondary forms of
glomerulosclerosis for many years and are now considered key
steps in the development of progressive renal disease (10, 11,
22, 24, 25, 40). Nephrin-podocin-CD2AP-induced AKT acti-
vation is associated with a strong inhibition of detachment-
induced apoptosis (anoikis) in podocytes. In contrast, podo-
cytes that lack CD2AP are highly susceptible to anoikis.
Furthermore, the targeted disruption of cd2ap results in apo-
ptotic cell death of podocytes in vivo (E. Bo¨ttinger, personal
communication). Thus, the structural and functional integrity
of the slit diaphragm proteins is required for the control of
complex biological programs, i.e., inhibition of apoptosis and
cell survival.
When nephrin was first isolated in 1998, the authors specu-
lated that the protein might initiate signaling within the podo-
cyte (20). Our findings suggest that the PI3K/AKT pathway
represents an important signaling target of slit diaphragm pro-
teins in several different model systems, including cultured
podocytes. Additional studies need to address the questions of
how nephrin-mediated PI3K/AKT activation is regulated in
vivo and which other PI3K-dependent pathways may be im-
portant for podocyte function and viability. A detailed under-
standing of the signaling events that occur at the cell-cell con-
tacts of glomerular podocytes will help us to understand the
pathogenesis of proteinuria.
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